Dr. Mark Epstein, a plastic surgeon in New York, shared the most common procedures his male clients get, from filler to ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Even as long routines and more involved treatments push us to the brink, pain powers beauty, argues Jessica DeFino.

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...